✦ LIBER ✦

PMH9 COST-EFFECTIVENESS OF CLINICALLY PROVEN TREATMENT STRATEGIES FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN FIVE JURISDICTIONS

✍ Scribed by M Schlander; O Schwarz; L Hakkaart-van Roijen; PS Jensen; U Persson; PJ Santosh; GE Trott

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH1 COST-EFFECTIVENESS OF CLINICALLY PR

✍ M Schlander; O Schwarz; EM Foster; L Hakkaart-van Roijen; PS Jensen; U Persson; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PIH29 the Cost Effectiveness of Clinical

✍ M. Schlander; A. Philipsen; O. Schwarz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMH40 COST-EFFECTIVENESS OF RITALINTM VE

✍ S Narayan; JW Hay 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PMH10 FUNCTIONAL IMPAIRMENT OF PATIENTS

✍ M Schlander; O Schwarz; L Hakkaart-van Roijen; PS Jensen; U Persson; PJ Santosh; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PMH37 THE COST-EFFECTIVENESS OF GUANFACI

✍ Erder, M.; Chen, K.; Wu, E.Q.; Hodgkins, P.; Sikirica, V. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PMH36 A COST-UTILTY ANALYSIS OF ATOMOXET

✍ A Diamantopoulos; M Lorenzo; M Happich; S Cottrell; H Scheijbeler 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB